Your browser doesn't support javascript.
loading
CRISPR-Cas9 technology: As an efficient genome modification tool in the cancer diagnosis and treatment.
Behrouzian Fard, Ghazaleh; Ahmadi, Mohammad Hossein; Gholamin, Mehran; Amirfakhrian, Razieh; Saberi Teimourian, Elahe; Karimi, Mohammad Ali; Hosseini Bafghi, Mahdi.
Afiliação
  • Behrouzian Fard G; Department of Laboratory Sciences, Faculty of Paramedical and Rehabilitation Sciences, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Ahmadi MH; Department of Laboratory Sciences, Faculty of Paramedical and Rehabilitation Sciences, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Gholamin M; Department of Laboratory Sciences, Faculty of Paramedical and Rehabilitation Sciences, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Amirfakhrian R; Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Saberi Teimourian E; Department of Laboratory Sciences, Faculty of Paramedical and Rehabilitation Sciences, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Karimi MA; Department of Laboratory Sciences, Faculty of Paramedical and Rehabilitation Sciences, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Hosseini Bafghi M; Department of Laboratory Sciences, Faculty of Paramedical and Rehabilitation Sciences, Mashhad University of Medical Sciences, Mashhad, Iran.
Biotechnol Bioeng ; 121(2): 472-488, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37986642

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Sistemas CRISPR-Cas / Neoplasias Limite: Humans Idioma: En Revista: Biotechnol Bioeng Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Sistemas CRISPR-Cas / Neoplasias Limite: Humans Idioma: En Revista: Biotechnol Bioeng Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Irã